Welcome To the U308 Corp HUB On AGORACOM
Edit this title from the Fast Facts Section
Message: U308 Corp. Announces c$400,000 Non-Brokered Private Placement
U3O8 Corp. Announces C$400,000 Non-Brokered Private Placement
Toronto, Ontario - October 01, 2018 - U3O8 Corp. (TSX: UWE), (OTCQB: UWEFF) ("U3O8 Corp." or the "Company") is pleased to announce a non-brokered private placement to raise approximately C$400,000 through the sale of approximately 1,600,000 Units (the "Units") at a price of C$0.25 per Unit to close on or about October 19, 2018 (the "Financing"). Each Unit will consist of a common share of the Company (a "Common Share") and one whole common share purchase warrant (a "Warrant"). Each Warrant will entitle the holder to purchase a Common Share at a price of C$0.40 and shall be valid for 36 months from the date of issuance.
In the event that subscriptions received for the Financing based on available prospectus exemptions exceed gross proceeds of C$400,000, the Company may increase the size of the Financing to 2,000,000 Units and gross proceeds of C$500,000.
Available Prospectus Exemptions to Subscribers
The Financing will be conducted pursuant to available prospectus exemptions including sales to accredited investors, close friends, family and business associates of directors and officers of the Company, as well as to existing shareholders of U3O8 Corp. by relying on the existing securityholder prospectus exemption (the "ESPE"), adopted by the Ontario Securities Commission (the "OSC") on February 5, 2015. Existing shareholders who would like to participate in the financing through the provisions of the ESPE must comply with the following:
In accordance with the ESPE, the Company confirms there is no material fact or material change related to the Company that has not been generally disclosed and that the Company's "core documents" and "documents", as defined under applicable securities laws, do not contain a misrepresentation.
If the Financing is over-subscribed, it is possible that a shareholder's subscription may not be accepted by the Company even though it is received.
This news release does not constitute an offer of securities for sale in the USA. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and such securities may not be offered or sold within the USA absent USA. registration or an applicable exemption from USA registration requirements.
Use of Proceeds
Proceeds of the Financing will be used for the completion of metallurgical test work on the Company's Laguna Salada uranium-vanadium deposit in Argentina, for general corporate and administrative purposes, and to enable the Company to consider exercising its right to maintain its 39% holding in the private frac sand company, South American Silica Corp. ("SAS"), should SAS undertake a private placement in light of positive developments in the frac sand industry.
The Company would like to clarify that the "Berlin Project" on which three geologists were recently killed by guerillas in Colombia, is not U3O8 Corp.'s Berlin Project. However, U3O8 Corp.'s Board of Directors and Management have taken note of the recent security incidents in Colombia and are considering various options.
Eligible finders who introduce an investor to the Financing will be paid a commission of 7% of the value of the client's investment in cash and 7% of the value of the client's investment in broker warrants (the "Broker Warrants"). The Broker Warrants will be exercisable into Common Shares of the Company at C$0.40 and will be valid for a period of 24 months from the date of closing of the Financing.
Related Party Transactions
Richard Spencer (CEO of the Company) and John Ross (CFO of the Company) are expected to participate in the Financing (the "Insider Participation") and their participation will constitute a related party transaction within the meaning of Multilateral Instrument 61-101 ("MI 61-101"). In the absence of exemptions, the Company would need to obtain a formal valuation for, and minority shareholder approval of, the related party transaction. The Company intends to rely on the exemptions from the valuation and minority shareholder approval requirements of MI 61-101 contained in Sections 5.5 and 5.7 of MI 61-101 in respect of the Insider Participation.
Residents of the USA
Under USA regulations, 35 US non-accredited investors may participate in the Financing. There is no limit on the number of accredited investors eligible to subscribe in the Financing from the USA.
Please inform us your interest in participating in this Financing via the following link on the Company's corporate website http://www.u3o8corp.com/subscription-guide/
Subscriptions will be accepted by the Company on a "first come, first served basis." Therefore, if the Financing is over-subscribed, it is possible that a shareholder subscription may not be accepted by the Company. Additionally, the Company reserves the right, in a situation of over-subscription, to reduce the number of Units available to each subscriber.
TSX Approval and Hold Periods
The Financing is subject to certain conditions including, but not limited to, the receipt of all necessary approvals, including final approval of the TSX and applicable securities regulatory authorities.
All securities issuable pursuant to the Financing will be subject to a statutory four (4) month hold period.
About U3O8 Corp.
Please login to post a reply